Joe Fielding
Founder and Managing Director of Active8 Consulting AG. Has over 30 Years working in an International environment in the Pharmaceutical Industry in different sectors such as Manufacturing Strategy, Operations and Global Engineering. His roles include Head of Global Engineering at Novartis, Site Director in GSK , Head Capital Planning in Roche/ Genentech and Lead for Technology of the Future at Roche/ Genentech.
His experience includes:
- Managing up to a $1.6 B portfolio of Capital projects at Roche & Genentech
- Developing 10 Year Vision for Technology at Roche
- Strategic Analysis for Site selection for new Products at Roche
- Increasing Site Manufacturing Capacity by 20% in GSK
- Leading Engineering due diligence review for $400M acquisition (Genentech) and participating in due diligences for a 1.0B acquisition (for PharmaBiosource)
- Responsibility for Global Engineering Teams in both Novartis (>80FTE’s) & GSK
- Has led Teams of over 260 people
- Project Managed Major Capital Projects > $ 80m
Expertise
- Strategic Planning and Analysis
- Capital Planning and forecasting
- Capital Project Management
- Engineering Team: Organisational design, team development and selection
Associations
- Member of International Society of Pharmaceutical Engineers
Education and Training
- BSc Chemical Engineering, Teesside University
- Financial Training, Harvard University
- Greenbelt Lean Six Sigma
- Class A certified, Oliver Wight
Languages
- Fluent in English and French